Drugs / Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00949572 | Sep 2009 → Jun 2010 | viral sexually transmitted disease | St George's, University of London | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00949572 ↗ |
| Modality | Vaccine | “We will use a licensed "HPV" vaccine as the source of antigens in this study.” NCT00949572 ↗ |
| Route | Intramuscular | “Intramuscular injection of HPV vaccine proteins” NCT00949572 ↗ |